PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830 | +121.9% | 17,357 | +88.7% | 0.00% | 0.0% |
| Q2 2023 | $374 | -16.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $446 | +27.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $351 | -99.9% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $462,000 | +25.2% | 9,200 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $369,000 | +7.6% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $343,000 | -6.3% | 9,200 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $366,000 | +7.0% | 9,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $342,000 | -12.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $389,000 | -10.8% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $436,000 | -22.3% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $561,000 | +30.5% | 9,200 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $430,000 | -7.9% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $467,000 | +13.9% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $410,000 | +6.5% | 9,200 | +14.7% | 0.00% | +50.0% |
| Q4 2019 | $385,000 | +42.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $271,000 | -24.9% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $361,000 | +19.5% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +9.8% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $275,000 | -27.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $377,000 | +39.6% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $270,000 | +24.4% | 8,019 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $217,000 | +61.9% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $134,000 | -16.2% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $160,000 | +8.8% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $147,000 | +86.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $79,000 | -9.2% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $87,000 | -22.3% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $112,000 | +100.0% | 8,019 | 0.0% | 0.00% | – |
| Q2 2016 | $56,000 | +7.7% | 8,019 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -67.5% | 8,019 | +62.8% | 0.00% | -100.0% |
| Q4 2015 | $160,000 | +21.2% | 4,926 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $132,000 | -44.3% | 4,926 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $237,000 | – | 4,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |